Exome analysis of oncogenic pathways and tumor mutational burden (TMB) in triple-negative breast cancer (TNBC): Results of the translational biomarker program of the neoadjuvant double-blind placebo ...

All cases, diagnosed with ALL between the 1st January 1980 and 31st December 2001, and registered by the MCTR were analysed. Ordnance Survey [OS] eight-digit grid references were allocated to each ...

Rationale: Patients with partial deficiency of recombination-activating genes 1 or 2 (RAG1/2) can present with a wide spectrum of primary immunodeficiencies including combined immunodeficiency with ...